Growth hormone treatment and risk of recurrence or progression of brain tumors in children: A review

Child's Nervous System

Volumn 25, Issue 3, 2009, Pages 273-279

  Bogarin, Roberto ^a   Steinbok, Paul ^b,c  

^a Division of Endocrinology   (Costa Rica)

^b BC CHILDREN S HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Brain tumor; Growth hormone; Second neoplasm; Tumor growth; Tumor recurrence

Indexed keywords

CYTOTOXIC AGENT; GROWTH HORMONE; HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; RECOMBINANT HORMONE; SOMATREM;

BRAIN TUMOR; CARCINOGENESIS; CHILD; CLINICAL TRIAL; DRUG SAFETY; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; INTRACRANIAL TUMOR; LEUKEMIA; LIFE EXPECTANCY; MORBIDITY; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; REVIEW; TUMOR GROWTH; TUMOR RECURRENCE;

BRAIN NEOPLASMS; CHILD; DISEASE PROGRESSION; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; LEUKEMIA; NEOPLASMS, SECOND PRIMARY; RECURRENCE; RISK ASSESSMENT;

EID: 59849111630     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-008-0790-6     Document Type: Review

References (29)

1. O Ali P Cohen KW Lee 2003 Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule Horm Metab Res 35 726 733
2. JA Alvarez RE Scully TL Miller FD Armstrong LS Constine DL Friedman SE Lipshultz 2007 Long-term effects of treatments for childhood cancers Curr Opin Pediatr 19 23 31
3. JS Barnholtz-Sloan RK Severson B Stanton M Hamre AE Sloan 2005 Pediatric brain tumors in non-Hispanics, Hispanics, African Americans and Asians: differences in survival after diagnosis Cancer Causes Control 16 587 592
4. RC Baxter AJ Butt LJ Schedlich JL Martin 2000 Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3 Growth Horm IGF Res 10 Suppl A S10 S11
5. P Cohen DR Clemmons RG Rosenfeld 2000 Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 10 297 305
6. F Darendeliler G Karagiannis P Wilton MB Ranke K Albertsson-Wikland D Anthony Price On Behalf of the Kigs International B 2006 Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database) Acta Paediatr 95 1284 1290
7. G Furstenberger HJ Senn 2002 Insulin-like growth factors and cancer Lancet Oncol 3 298 302
8. E Giovannucci 1999 Insulin-like growth factor-I and binding protein-3 and risk of cancer Horm Res 51 Suppl 3 34 41
9. HK Gleeson SM Shalet 2004 The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours Endocr Relat Cancer 11 589 602
10. EN Gonc N Yordam A Ozon A Alikasifoglu N Kandemir 2004 Endocrinological outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases Pediatr Neurosurg 40 112 119
11. A Grimberg P Cohen 2000 Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis J Cell Physiol 183 1 9
12. JG Gurney NS Kadan-Lottick RJ Packer JP Neglia CA Sklar JA Punyko M Stovall Y Yasui HS Nicholson S Wolden DE McNeil AC Mertens LL Robison 2003 Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study Cancer 97 663 673
13. N Karavitaki JT Warner A Marland B Shine F Ryan J Arnold HE Turner JA Wass 2006 GH replacement does not increase the risk of recurrence in patients with craniopharyngioma Clin Endocrinol (Oxf) 64 556 560
14. T Mochizuki K Sakai M Iwashita 2006 Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro Growth Horm IGF Res 16 202 210
15. T Moshang Jr AC Rundle DA Graves J Nickas A Johanson A Meadows 1996 Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience J Pediatr 128 S4 S7
16. DM Niu WY Guo HC Pan TT Wong 2002 Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement Childs Nerv Syst 18 164 165
17. KC Oeffinger DA Eshelman GE Tomlinson GR Buchanan 1998 Programs for adult survivors of childhood cancer J Clin Oncol 16 2864 2867
18. RJ Packer LN Sutton R Elterman B Lange J Goldwein HS Nicholson L Mulne J Boyett G D'Angio K Wechsler-Jentzsch 1994 Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy J Neurosurg 81 690 698
19. RJ Packer JM Boyett AJ Janss T Stavrou L Kun J Wisoff C Russo R Geyer P Phillips M Kieran M Greenberg S Goldman D Hyder R Heideman D Jones-Wallace GP August SH Smith T Moshang 2001 Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control J Clin Oncol 19 480 487
20. AT Reddy AJ Janss PC Phillips HL Weiss RJ Packer 2000 Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy Cancer 88 2189 2193
21. MM Rutter SR Rose 2007 Long-term endocrine sequelae of childhood cancer Curr Opin Pediatr 19 480 487
22. M Schmiegelow S Lassen HS Poulsen U Feldt-Rasmussen K Schmiegelow H Hertz J Muller 2000 Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors Horm Res 54 53 59
23. M Shim P Cohen 1999 IGFs and human cancer: implications regarding the risk of growth hormone therapy Horm Res 51 Suppl 3 42 51
24. CA Sklar AC Mertens P Mitby G Occhiogrosso J Qin G Heller Y Yasui LL Robison 2002 Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study J Clin Endocrinol Metab 87 3136 3141
25. AJ Swerdlow 2000 Design and interpretation of studies of the risk of cancer and other long-term morbidity and mortality after growth hormone treatment Growth Horm IGF Res 10 318 323
26. AJ Swerdlow RE Reddingius CD Higgins HA Spoudeas K Phipps Z Qiao WD Ryder M Brada RD Hayward CG Brook PC Hindmarsh SM Shalet 2000 Growth hormone treatment of children with brain tumors and risk of tumor recurrence J Clin Endocrinol Metab 85 4444 4449
27. Y Tao V Pinzi J Bourhis E Deutsch 2007 Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway-therapeutic perspectives in cancer Nat Clin Pract Oncol 4 591 602
28. M Weiss L Sutton V Marcial B Fowble R Packer R Zimmerman L Schut D Bruce G D'Angio 1989 The role of radiation therapy in the management of childhood craniopharyngioma Int J Radiat Oncol Biol Phys 17 1313 1321
29. D Wyatt 2004 Lessons from the national cooperative growth study Eur J Endocrinol 151 Suppl 1 S55 S59